Argenx announces results of annual general meeting of shareholders

May 3 , 2023 amsterdam , the netherlands – argenx se (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its annual general meeting of shareholders held yesterday. all items on the agenda received a majority of votes in favor except for agenda item 3 (advisory non-binding vote on the 2022 remuneration report).
ARGX Ratings Summary
ARGX Quant Ranking